{
    "name": "polyethylene glycol/electrolytes/sodium ascorbate/ascorbic acid",
    "comment": "Rx",
    "other_names": [
        "MoviPrep",
        "Plenvu"
    ],
    "classes": [
        "Bowel Preps"
    ],
    "source": "https://reference.medscape.com/drug/moviprep-plenvu-polyethylene-glycol-electrolytes-sodium-ascorbate-ascorbic-acid-999537",
    "pregnancy": {
        "common": [
            "There are no available data with in pregnant women to inform a drug-associated risk for adverse developmental outcomes",
            "Animal reproduction studies have not been conducted"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "No data are available to assess the presence in human milk, the effects on the breastfed child, or the effects on milk production"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "GI obstruction",
                "Bowel perforation",
                "Gastric retention",
                "Ileus",
                "Toxic colitis",
                "Toxic megacolon"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Use with caution in patients using concomitant medications that increase the risk of electrolyte abnormalities",
                "Use with caution in patients with severe ulcerative colitis, ileus, gastrointestinal obstruction",
                "Product contains polyethylene glycol (PEG) and lemon flavoring (containing citral, lemon, and lime oil, maltodextrin, xanthan gum, and vitamin E) and may cause serious hypersensitivity reactions including anaphylaxis, angioedema, rash, urticaria, and pruritus; inform patients of signs and symptoms of anaphylaxis, and instruct them to seek immediate medical care should signs and symptoms occur",
                "Serious arrhythmias (including atrial fibrillation) associated with use of ionic osmotic laxative products for bowel preparation; these occur predominantly in patients with underlying cardiac risk factors and electrolyte disturbances; consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias",
                "Use with caution and observe unconscious or semiconscious patients with impaired gag reflex or other swallowing abnormalities or those who are otherwise prone to regurgitation or aspiration during administration; observe these patients during administration, especially if it is administered via nasogastric tube",
                "Do not combine product with starch-based thickeners; polyethylene glycol (PEG), a component of the mixture, when mixed with starch-thickened liquids, reduces viscosity of the starch-thickened liquid; when a PEG-based product used for another indication was mixed in starch-based pre-thickened liquids used in patients with dysphagia, thinning of the liquid and cases of choking and potential aspiration were reported",
                "Since product contains sodium ascorbate and ascorbic acid, use with caution in patients with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency",
                "Phenylketonurics can be harmful to patients with phenylketonuria (PKU); contains phenylalanine, a component of aspartame; before prescribing drug to patient with PKU, consider combined daily amount of phenylalanine from all sources, including this drug combination",
                "If severe vomiting occurs, check serum electrolytes",
                "Elderly patients are more likely to have decreased hepatic, renal or cardiac function and may be more susceptible to adverse reactions resulting from fluid and electrolyte abnormalities",
                "Serious arrythmias reported"
            ],
            "specific": [
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Use with caution in patients with renal impairment or patients taking concomitant medications that affect renal function (such as diuretics, ACE inhibitors, angiotensin receptor blockers, or nonsteroidal anti-inflammatory drugs; patients may be at risk for renal injury; advise patients of the importance of adequate hydration before, during, and after use and consider performing pre-dose and post-colonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients",
                        "Therapy can reduce absorption of other co-administered drugs; administer oral medications at least 1 hour before start of administration of each dose",
                        "Concurrent use of stimulant laxatives may increase risk of mucosal ulceration or ischemic colitis; avoid use of stimulant laxatives (e.g., bisacodyl, sodium picosulfate) while taking therapy"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Malaise",
            "percent": "18-27"
        },
        {
            "name": "Nausea",
            "percent": "14-47"
        },
        {
            "name": "Abdominal pain",
            "percent": "13-39"
        },
        {
            "name": "Vomiting",
            "percent": "17"
        },
        {
            "name": "Abdominal distension",
            "percent": "12"
        },
        {
            "name": "Anal discomfort",
            "percent": "59.8"
        },
        {
            "name": "Thirst",
            "percent": "51.5"
        },
        {
            "name": "nausea",
            "percent": "47.3"
        },
        {
            "name": "Abdominal pain",
            "percent": "39.1"
        },
        {
            "name": "Sleep disorder",
            "percent": "34.9"
        },
        {
            "name": "Rigors",
            "percent": "33.7"
        },
        {
            "name": "Hunger",
            "percent": "30.2"
        },
        {
            "name": "Malaise",
            "percent": "26.6"
        },
        {
            "name": "Vomiting",
            "percent": "7.8"
        },
        {
            "name": "Upper abdominal pain",
            "percent": "5.6"
        },
        {
            "name": "Dyspepsia",
            "percent": "2.8"
        },
        {
            "name": "Vomiting",
            "percent": "7.1"
        },
        {
            "name": "Dizziness",
            "percent": "6.5"
        },
        {
            "name": "Headache",
            "percent": "1.8"
        }
    ]
}